These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16256998)

  • 21. Outcome of fertility-preserving treatment in young women with endometrial carcinomas.
    Niwa K; Tagami K; Lian Z; Onogi K; Mori H; Tamaya T
    BJOG; 2005 Mar; 112(3):317-20. PubMed ID: 15713146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term conservative therapy for endometrial adenocarcinoma in young women.
    Yahata T; Fujita K; Aoki Y; Tanaka K
    Hum Reprod; 2006 Apr; 21(4):1070-5. PubMed ID: 16361282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fertility-sparing surgery for malignancies in women.
    Gershenson DM
    J Natl Cancer Inst Monogr; 2005; (34):43-7. PubMed ID: 15784822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma.
    Bahamondes L; Ribeiro-Huguet P; de Andrade KC; Leon-Martins O; Petta CA
    Acta Obstet Gynecol Scand; 2003 Jun; 82(6):580-2. PubMed ID: 12780432
    [No Abstract]   [Full Text] [Related]  

  • 25. Conservative management of young women with endometrial carcinoma or complex atypical hyperplasia: report of three cases and literature review.
    Karimi-Zarchi M; Mousavi AS; Behtash N; Chiti Z; Bokaie M
    Eur J Gynaecol Oncol; 2011; 32(6):695-8. PubMed ID: 22335041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
    Yu M; Yang JX; Wu M; Lang JH; Huo Z; Shen K
    Fertil Steril; 2009 Dec; 92(6):2122-4. PubMed ID: 19591991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage IV endometrial cancer after failed conservative management: a case report.
    Kothari R; Seamon L; Cohn D; Fowler J; O'Malley DM
    Gynecol Oncol; 2008 Dec; 111(3):579-82. PubMed ID: 18395778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option.
    Gadducci A; Spirito N; Baroni E; Tana R; Genazzani AR
    Gynecol Endocrinol; 2009 Oct; 25(10):683-91. PubMed ID: 19562604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia.
    Janicek MF; Rosenshein NB
    Gynecol Oncol; 1994 Mar; 52(3):373-8. PubMed ID: 8157194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
    Mittal K; Da Costa D
    Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma.
    Kudesia R; Singer T; Caputo TA; Holcomb KM; Kligman I; Rosenwaks Z; Gupta D
    Am J Obstet Gynecol; 2014 Mar; 210(3):255.e1-4. PubMed ID: 24211482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of medroxyprogesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancer.
    Tamauchi S; Kajiyama H; Utsumi F; Suzuki S; Niimi K; Sakata J; Mizuno M; Shibata K; Kikkawa F
    J Obstet Gynaecol Res; 2018 Jan; 44(1):151-156. PubMed ID: 29121428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system.
    Kresowik J; Ryan GL; Van Voorhis BJ
    Obstet Gynecol; 2008 Feb; 111(2 Pt 2):547-9. PubMed ID: 18239018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium.
    Minaguchi T; Nakagawa S; Takazawa Y; Nei T; Horie K; Fujiwara T; Osuga Y; Yasugi T; Kugu K; Yano T; Yoshikawa H; Taketani Y
    Cancer Lett; 2007 Apr; 248(1):112-22. PubMed ID: 16919866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of conservative treatment and subsequent assisted reproductive technology for patients with early-stage endometrial adenocarcinoma and poor fertility potential.
    Tong XM; Zhu HY; Lin XN; Jiang LY; Xu WH; Liu L; Zhang SY
    Chin Med J (Engl); 2012 Oct; 125(19):3578-80. PubMed ID: 23044328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hysteroscopic view in atypical endometrial hyperplasias: A correlation with pathologic findings on hysterectomy specimens.
    Garuti G; Mirra M; Luerti M
    J Minim Invasive Gynecol; 2006; 13(4):325-30. PubMed ID: 16825075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of fertility-sparing treatment with medroxyprogesterone acetate for atypical hyperplasia and endometrial carcinoma in young Japanese women.
    Kataoka H; Mori T; Yamamoto T; Sawada M; Kuroboshi H; Tatsumi H; Iwasaku K; Kitawaki J
    Eur J Gynaecol Oncol; 2014; 35(1):11-5. PubMed ID: 24654454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sparing fertility in young patients with endometrial cancer.
    Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis.
    Koskas M; Uzan J; Luton D; Rouzier R; Daraï E
    Fertil Steril; 2014 Mar; 101(3):785-94. PubMed ID: 24388202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combined GnRH-agonist and intrauterine levonorgestrel-releasing system treatment of complicated atypical hyperplasia and endometrial cancer: a pilot study.
    Pashov AI; Tskhay VB; Ionouchene SV
    Gynecol Endocrinol; 2012 Jul; 28(7):559-61. PubMed ID: 22296608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.